Back to search

Article

Transcriptomic Changes and Biomarkers in Barrett's Metaplasia, Dysplasia and Cancer

2026-08-25

Abstract excerpt

Esophageal adenocarcinoma (EAC) has a poor five-year survival rate and one of the fastest-rising incidences of any cancer. The presence of dysplasia in Barrett's esophagus (BE) is the main risk factor for EAC development and guides clinical management. Unfortunately, the current histopathological diagnosis of dysplasia is unreliable, with poor inter-observer agreement, highlighting the need for novel biomarkers th...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
eb8c5b0b-a5e4-53a9-a726-8483a5795d3c
DOI
10.64898/2026.08.25.746910
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Transcriptomic Changes and Biomarkers in Barrett's Metaplasia, Dysplasia and CancerDOI 10.64898/2026.08.25.746910
Select a neighboring publication to make it the new centre.